These results reveal a role for Egr1 in blocking energy expenditure via direct Ucp1 transcription repression and highlight Egr1 as a therapeutic target for counteracting obesity. The gene discussed is EGR1; the disease is obesity due to melanocortin 4 receptor deficiency.